| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |